A sub-group analysis of the TRIUMPH study (@RahulArgula, @ValMcLaughlinMD, et al.) which assessed inhaled treprostinil for the treatment of #PulmonaryArterialHypertension in intermediate-high risk patients will be presented as well. 5/8
#PulmonaryArterialHypertension